https://medicalxpress.com/news/2024-04- ... trial.html
by Robin Foster
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
There is currently no vaccine for chlamydia, which is the most common bacterial STI in the United States, according to the U.S. Centers for Disease Control and Prevention.
In the new trial results, published April 11 in the journal Lancet Infectious Diseases, the vaccine was found to be safe and it also prompted an antibody response.
"This is desperately needed," David Harvey, executive director of the National Coalition of STD Directors, told NBC News. "We have the highest STI rates in America since the 1950s and possibly beyond."
Chlamydia also remains one of the most common causes of infertility in women, Dr. Jay Varma, a professor of population health sciences at Weill Cornell Medicine in New York City, told NBC News. If left untreated, chlamydia can cause pelvic inflammatory disease, which makes it harder to get pregnant.